Oxford Immunotech (AgeTech UK) Covid-19
Treatment for chronic diseases for patients with compromised immuno-system, e.g HIV/AIDS, might be Covid-relevant.
Investors
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership